Search for: "Teva USA" Results 41 - 60 of 714
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Dec 2021, 8:33 am by Lawrence B. Ebert
: Teva lost its appeal to the CAFC in the case involving mifepristone [here, Korlym, a 300 mg mifepristone tablet ] : Teva faults the Board for, in its view, committing two legal errors. [read post]
27 Jul 2015, 6:07 pm by LTA-Editor
By Miriam Swedlow Despite overruling the Federal Circuit’s prior practice of reviewing all aspects of patent claim construction de novo, the Supreme Court’s ruling in Teva Pharmaceuticals USA, Inc. v. [read post]
14 Apr 2024, 9:19 pm by Patent Docs
Teva Pharmaceuticals USA, Inc. the Federal Circuit reminds us that most verities in patent law are not eternal and frequently subject to case-by-case interpretation, in this case the purported verity being that reciting the indefinite article ("a") in a patent claim is construed to mean "one or more. [read post]
30 Mar 2008, 8:26 pm
USA, No. 05-5727 (D.N.J. 2008) Eisai Co., Ltd., the Japanese manufacturer of Aricept (donepezil hydrochloride), has won a preliminary injunction against Teva Pharmaceuticals USA, Inc., keeping Teva's generic version of Aricept off the market for the time being. [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
17 May 2009, 9:55 pm
By Andrew Williams -- Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix ®. [read post]
26 May 2015, 7:06 am by Docket Navigator
The court denied defendant's motion to reopen the judgment and rejected its argument that Teva Pharmaceuticals USA, Inc. v. [read post]
17 Oct 2018, 7:49 pm by Brian Craig
The Federal Circuit found the district court committed no error in construing claim terms as non-limiting for nonobviousness purposes or in invalidating as obvious all asserted claims of the Copaxone patents, including a 40-milligram dosage three times per week (Teva Pharmaceuticals USA, Inc. v. [read post]
9 Oct 2014, 9:59 pm by Patent Docs
By Andrew Williams -- Next week, the Supreme Court will hear oral arguments in the Teva Pharmaceuticals USA, Inc. v. [read post]
7 Jan 2022, 12:56 pm by luiza
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
7 Jan 2022, 12:56 pm by luiza
In a significant development in the ongoing effort to assess blame and responsibility for the opioid epidemic, which has led to the deaths of hundreds of thousands of individuals and ravaged communities throughout the United States, on December 30th, after a six-month trial, a New York jury found that Teva Pharmaceuticals USA, Inc. [read post]
5 Oct 2020, 1:15 pm by Rebecca Tapscott
Teva Pharmaceuticals USA, Inc., the United States Court of Appeals for the Federal Circuit (CAFC) on Friday reversed a district court’s motion for judgment as a matter of law (JMOL) for Teva, finding that Teva was liable for induced infringement of GlaxoSmithKline's (GSK’s) patent directed to a method of treating Congestive Heart Failure (CHF) using carvedilol..... [read post]
31 Mar 2014, 8:47 pm by Patent Docs
By Andrew Williams -- Earlier today, the Supreme Court granted certiorari in the Teva Pharmaceuticals USA, Inc. v. [read post]